반응식
[O:1]=[C:2]1[NH:8][CH2:7][CH2:6][CH2:5][N:4]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:3]1.Cl[CH2:17][O:18][CH2:19][C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=1>>[CH2:19]([O:18][CH2:17][N:8]1[CH2:7][CH2:6][CH2:5][N:4]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:3][C:2]1=[O:1])[C:20]1[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=1참가 물질
3
실험 절차
The title compound was prepared from tert-butyl hexahydro-3-oxo-1H-1,4-diazepine-1-carboxylate (Example 2, Step B) and benzyl chloromethyl ether essentially following the method described in Example 2, Step C.
출처 및 근거
- ORD 기록
- ord-a743467fa3434085bb85b9fc2369c39b
- 출처 데이터셋
- uspto-grants-2006_09
- 특허 번호
- US07101871B2
연결된 노트
불러오는 중…